References
- Parkin DM, Bray F, Ferlay J. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2)74–108
- El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 134(6)1752–1763
- Reddy LH. Drug delivery to tumours: Recent strategies. J Pharma Pharmacol 2005; 57(10)1231–1242
- Wust P, Gneveckow U, Johannsen M, Böhmer D, Henkel T, Kahmann F, Sehouli J, Felix R, Ricke J, Jordan A. Magnetic nanoparticles for interstitial thermotherapy–Feasibility, tolerance and achieved temperatures. Int J Hyperthermia 2006; 22(8)673–685
- Lindegaard JC, Nielsen OS, Overgaard J. A comparison between the effect of step-down heating in a tumour and a normal tissue in vivo. Int J Hyperthermia 1991; 7(3)519–526
- Adachi Y, Mizuno S, Yoshida M. Efficient large-scale purification of non-histone chromosomal proteins HMG1 and HMG2 by using Polybuffer-exchanger PBE94. J Chromatogr 1990; 530(1)39–46
- Arica B, Caliş S, Kaş H, Sargon M. Hincal A. 5-Fluorouracil encapsulated alginate beads for the treatment of breast cancer. Int J Pharm 2002; 242(1–2)267–269
- Schotman SN, Schraa EO, Marquet RL, Zondervan PE, Ijzermans JN. Hepatocellular carcinoma and liver transplantation: An animal model. Transpl Int 1998; 11(Suppl.1)S201–205
- Vinsova J, Vavrikova E. Recent advances in drugs and prodrugs design of chitosan. Curr Pharm Des 2008; 14(13)1311–1326
- Orel VE, Dzyatkovskaya NN, Romanov AV, Kozarenko TM. The effect of electromagnetic field and local inductive hyperthermia on nonlinear dynamics of the growth of transplanted animal tumors. Exp Oncol 2007; 29(2)156–158
- Santhi K, Dhanaraj SA, Rajendran SD, Raja K, Ponnusankar S, Suresh B. Nonliposomal approach-A study of preparation of egg albumin nanospheres containing amphotericin-B. Drug Dev Ind Pharm 1999; 25(4)547–551
- Cao H, Gan J, Wang S, Xuan S, Wu Q, Li C, Wu C, Hu C, Huang G. Novel silica-coated iron-carbon composite particles and their targeting effect as a drug carrier. J Biomed Mater Res A 2008; 86(3)671–677
- Cao H, Gan J, Wang S, Xuan S, Wu Q, Li C, Wu C, Hu C, Huang G. Novel silica-coated iron-carbon composite particles and their targeting effect as a drug carrier. J Biomed Mater Res A 2008; 86(3)671–677
- Wang Q, Zhang N, Hu X, Yang J, Du Y. Chitosan/starch fibers and their properties for drug controlled release. Eur J Pharm Biopharm 2007; 66(3)398–404
- Chen JH, Ling R, Yao Q, Wang L, Ma Z, Li Y, Wang Z, Xu H. Enhanced antitumor efficacy on hepatoma-bearing rats with adriamycin-loaded nanoparticles administered into hepatic artery. World J Gastroenterol 2004; 10(13)1989–1991
- Ito A, Matsuoka F, Honda H, Kobayashi T. Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Immunol Immunother 2004; 53(1)26–32
- Ito A, Tanaka K, Kondo K, Shinkai M, Honda H, Matsumoto K, Saida T, Kobayashi T. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci 2003; 94(3)308–313
- Jones SK, Winter J, Gray BN. Treatment of experimental rabbit liver tumors by selectively targeted hyperthermia. Int J Hypertherma 2002; 8(2)17–28
- Schneider BJ, El-Rayes B, Muler JH, Philip PA, Kalemkerian GP, Griffith KA, Zalupski MM. Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site. Cancer 2007; 110(4)770–775
- Yan S, Zhang D, Gu N, Zheng J, Ding A, Wang Z, Xing B, Ma M, Zhang Y. Therapeutic effect of Fe2O3 nanoparticles combined with magnetic fluid hyperthermia on cultured liver cancer cells and xenograft liver cancers. J Nanosci Nanotechnol 2005; 5(8)1185–1192
- Gallo JM, Gupta PK, Hung CT, Perriet DG. Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat. J Pharm Sci 1989; 78(3)190–194
- Ohtsubo T, Igawa H, Saito T, Matsumoto H, Park H, Song CW, Kano E, Saito H. Enhancement of cell killing by induction of apoptosis after treatment with mild hyperthermia at 42°C and cisplatin. Radiat Res 2001; 156(1)103–109
- von Ardenne M, Chaplain RA, Reitnauer PG. Selective injury to cancer cells by a combined attack with acidification, heat, vitamin A, dimethyl sulfoxide and other agents facilitating the release of lysosomal enzymes. Arch Geschwulstforsch 1969; 33(4)331–344
- Ohtsubo T, Saito H, Tanaka N, Matsumoto H, Sugimoto C, Saito T, Hayashi S, Kano E. Enhancement of cisplatin sensitivity and platinum uptake by 40°C hyperthermia in resistant cells. Cancer Lett 1997; 119(1)47–52
- Toyota N, Strebel FR, Stephens LC, Rowe W, Matsuda H, Oshiro T, Jenkins GN, Bull JM. Effect of altered duration of 41.5°C whole body hyperthermia in combination with cis-diamminedichloroplatinum (II) on tumor and normal tissue apoptosis and tumor response in rats. Oncol Rep 1998; 5(5)1231–1236
- Häfeli UO. Magnetically modulated therapeutic systems. Int J Pharm 2004; 277(1–2)19–24